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Abstract 
Periodontal diseases are complex bacteria-induced infections characterised by an  inflammatory host response to 
plaque microbiota and their by-products. Most of these  microorganisms have virulence factors capable of causing 
massive tissue destruction both  directly, through tissue invasion and the production of harmful substances, or  in-
directly, by activation of host defense mechanisms, creating an inflammatory  infiltrate of potent catabolic activity 
that can interfere with normal host defense  mechanisms. In response to the aggression, host defense mechanisms 
activate innate and  adaptive immune responses. Our aim is to offer a general overview of the main mechanisms 
involved in the host  response to bacterial aggression in periodontitis, such as lipopolysaccharide receptor  CD14, 
complement system, polymorphonuclear neutrophils, antibodies and immunoglobulins.
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Introduction
Periodontitis is a complex infection of bacterial origin 
in which multiple factors are implicated. It is character-
ised by an inflammatory host response against microor-
ganisms of the bacterial plaque and their products (1). 
Most of these microorganisms can produce tissue de-
struction (1, 2) in two ways: (i) directly, through inva-
sion of the tissues and the production of harmful sub-
stances that induce cell death and tissue necrosis; and 
(ii) indirectly, through activation of inflammatory cells 
that can produce and release mediators that act on effec-
tors, with potent proinflammatory and catabolic activ-
ity. This action plays a crucial role in the destruction 
of periodontal tissue, while some bacteria also interfere 
with the normal host defence mechanism by deactivat-
ing specific antibodies or inhibiting the action of phago-
cyte cells (3).
The pathogenesis of periodontal destruction involves 
the sequential activation of different components of the 
host immune and inflammatory response, aimed in the 
first place at defending the tissues against bacterial ag-
gression, reflecting the essentially protective role of the 
response. However, it also acts as a mediator of this de-
struction (4).
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The proportion of damage caused by direct effects of 
the bacteria and that caused by indirect host response-
mediated action have yet to be established (3). Although 
numerous bacteria can degrade tissue directly, Birked-
al-Hansen et al (5) suggested that host connective tissue 
is mainly degraded by the host. Thus, the loss of con-
nective tissue is a defence mechanism; the host attempts 
self-protection by the apical proliferation of junction ep-
ithelium, escaping from the toxic root surface to avoid 
lesion progression (1-5). 
According to the basic principles of epidemiology in in-
fectious diseases, the manifestation of a disease (Fig. 1) 
depends on interaction between environmental, micro-
biologic agent- and host-related factors. Thus, specific 
environmental and genetic factors are likely to deter-
mine individual susceptibility for periodontal disease, 
i.e., for the tissue to be colonised by pathogenic microbi-
ota and infection to develop, giving rise to a destructive 
inflammatory response (5). The presence of periodonto-
pathogenic bacterial microbiota is a necessary but not 
sufficient condition for the development of periodontal 
disease, which can be defined as a mixed infection that 
causes periodontal destruction in a susceptible host (4). 
Host defence mechanisms
Host defence mechanisms, which interrelate with each 
other, represent the response of the host to aggression. 
This response involves the activation of both innate and 
adaptive elements of the immune system (6).
In periodontitis, bacteria induce an inflammatory re-
sponse that, alongside their direct destructive effects, is 
largely responsible for the tissue destruction observed. 
Inflammatory and immune processes dynamically in-
teract in periodontitis (4), although the great majority of 
periodontal responses are immunological (1).
Gingival crevicular fluid (GCF) is a serum transudate 
that originates in the gingival plexus of gingival corium 
blood vessels, subjacent to the epithelium lining of the 
dentogingival space. Because it passes through sulcular 
and junctional epithelia and periodontal tissues, it con-
tains molecular biological markers. If the periodontal 
inflammation and its severity increase, the GCF aug-
ments. GCF contains most of the serum components 
present in the blood but is enriched with specific com-
ponents in periodontitis due to the infiltration of inflam-
matory cells, reflecting the local metabolic state of the 
periodontal tissues (7-9). Numerous methods for sam-
pling GCF have been developed to date, and over 90 
different GCF components have been assessed for peri-
odontal diagnosis (8).
1. Lipopolysaccharide Receptor: CD 14
Lipopolysaccharide (LPS) is a virulence factor in the 
membrane of Gram-negative bacteria membrane, com-
prising a portion known as lipid A, antigen O and an 
oligosaccharide that binds them together. Among these, 
it is lipid A that can trigger an inflammatory response. 
LPS is a powerful activator of the innate immune sys-
tem, which it achieves by stimulating the Toll-like re-
ceptor 4 (TLR4), a cell surface protein that recognizes 
bacterial products (7, 10). When bacterial LPS enters 
the blood circulation, it induces multiple biological re-
sponses, including fever, shock, intravascular coagula-
tion, and even death. Some authors have pointed out that 
serum LPS concentrations rise in periodontitis, increas-
ing the risk of systemic problems (7). The LPS of oral 
bacteria have a marked effect on most cell types found 
in periodontal tissues, including macrophages, lympho-
cytes, fibroblasts and osteoblasts/osteoclasts. Much of 
the physiopathology of periodontal diseases can be ex-
plained by the local biological activity of LPS (7). 
Fig. 1. Factors implicated in periodontal disease.
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LPS binding protein (LBP) is an acute phase reactant, 
synthesized by hepatocytes, which catalyses LPS trans-
fer to its receptor, membrane CD14 present in mono-
cytes/macrophages or soluble CD14 (sCD14) (7, 10) 
(Fig. 2).
Activation of the CD14 receptor activates monocytes 
and endothelial cells via a TLR4-dependent pathway, 
producing the secretion of proinflammatory molecules 
such as interleukin 1 (IL-1), Tumour Necrosis Factor 
(TNF), prostaglandin E2 (PG-E2) and interleukin-6 
(IL-6). These molecules in turn produce the release of 
secondary inflammatory mediators, including platelet 
activation factor (PAF), bioactive aminases (bradykinin 
and histamine) and prostaglandins (7, 8, 10, 11). 
Septic shock exhibits a similar sequence to that ob-
served in periodontal disease: exposure to LPS, release 
of cytokines and activation of inflammatory mediators 
(11).
In septic shock, patients with similar LPS values can 
present different clinical features and cytokine levels, 
the latter resulting from an alteration in the functioning 
of the inflammatory response (11). Periodontitis can be 
considered a disease caused by bacterial microbiota as-
sociated with gingivitis in an individual who presents 
an abnormal inflammatory response.
Hayashi et al. (11) demonstrated the presence of higher 
CD14 levels in patients with periodontal disease com-
pared with healthy individuals, and suggested that this 
increase was related to chronic exposure to LPS. Other 
authors have also demonstrated increase in serum of 
LPB and antibodies against LPS of periodontopatho-
gens in periodontal patients (7).             
2. Complement system
The complement system is a group of around 30 pro-
teins that participate in tissue destruction and in inflam-
matory processes. It can be activated by the alternative 
pathway (LPS or other bacterial products) or by the 
classical pathway (detection of antigen-antibody com-
plexes), giving rise to bacterial opsonisation (2).
Complement activation is considered a protective 
mechanism in antibacterial immunity, although some 
products of this pathway may cause tissue destruction. 
Numerous components of the complement system have 
been found in the GCF of periodontal patients, either 
derived from serum or produced by local system activa-
tion (9). Many studies have underlined the importance 
of the complement system in periodontal disease and 
its role in protecting against periodontopathogenic bac-
teria (1). Activation of the complement system is one 
of the earliest host immune responses in the gingival 
crevicular space (Fig.3). The presence of bacteria in the 
gingival pocket can activate this system by either the 
classical or alternative pathway (1). C3 activation var-
ies with the severity of periodontal inflammation, and 
this can help to differentiate among different forms of 
periodontitis (9).
Bacteria related to periodontal disease have different 
mechanisms to evade the complement system (2, 12). 
Some strains present polysaccharides on their surface, 
which mask the molecules that activate the complement 
(LPS), increasing the affinity of molecules that inhibit 
this activity or creating a steric impediment. In other 
words, hydrocarbon structures on the surface of the 
bacteria can determine their interaction with compo-
nents of the complement system (12). 
Furthermore, some periodontopathogenic bacteria have 
proteolytic activity on their cell surface (Fig. 3) that can 
degrade certain components of the complement system, 
such as C3 and C5, thereby avoiding opsonisation. A 
further strategy is the release into the medium of mol-
ecules that can bind to the complement, reducing the 
activity of this system on the bacteria (12). 
Bacteria such as Porphyromonas gingivalis (Pg) and 
Actinobacillus actinomycetemcomitans (Aa) have com-
plex hydrocarbon structures with high antigenic and 
immunogenic potency that can trigger a strong IgG2 
response. IgG2 does not generally fix complement ef-
fectively (13). 
Cutler et al. (14) demonstrated that the opsonisation and 
clearance of Pg by neutrophils required the response of 
specific Ig G-type antibodies. Pg enzyme neutralising 
antibodies are essential to ensure the normal phagocytic 
activity of neutrophils when the alternative complement 
pathway is ineffective. Hence, these antibodies do not 
function as opsonins but rather serve to neutralise toxic 
bacterial products, such as proteases.
3. Polymorphonuclear Neutrophils (PMN)
Neutrophils are the main cell type in the gingival pock-
et and form the first line of defence against periodonto-
pathogenic bacteria (Fig. 3) (13). Neutrophil infiltration 
Fig. 2. Binding of lipopolysaccharide (LPS) to its receptor (CD14) 
prior to binding to LPS binding protein (LBP).       
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takes place in the periodontal tissue in closest proxim-
ity to the colonized root surface (10). Inflammatory cell 
infiltrate in gingival tissue and GCF is predominantly 
formed by neutrophils, and B cells and plasma cells are 
also present (9).Although monocytes are phagocytic 
cells, they make up the second line of defence and are 
only activated if the infection persists, when the neutro-
phils become ineffective (6).
Once in tissue, it is postulated that neutrophils move 
among cells using the ICAM receptor, following a con-
centration gradient of IL-8, a chemotactic cytokine for 
neutrophils (2, 10). In the gingival pocket, active neu-
trophils attempt microbial elimination by phagocytosis. 
However, some periodontopathogenic bacteria, such as 
Pg and Aa, are able to evade the neutrophils, producing 
a constant flow of these phagocytes into the gingival 
crevicular space, giving rise to a continuous accumula-
tion and degranulation due to an ineffective phagocyto-
sis (10, 15). Degranulation of the PMN is accompanied 
by the release of endogenous proteases that, alongside 
the bacterial proteases, produce degradation of the cell 
matrix. The host proteases are regulated by endogenous 
inhibitors, which can also modulate the activity of bac-
terial proteases. Nevertheless, the latter can deactivate 
the inhibitors, causing continuous destruction of the 
periodontal tissue (15).
The importance of PMN in periodontal disease is il-
lustrated by the fact that quantitative or qualitative de-
ficiencies in these cells, either congenital (cyclic neu-
tropenia, Chediak-Higashi syndrome, Papillon-Lefèvre 
syndrome or leukocyte adhesion deficiency) or drug-
induced (phenylbutazone, penicillin) are associated 
with a marked destruction of periodontal tissues (2, 6, 
10). Hence, the normal functioning of neutrophils is an 
essential element of host resistance to periodontal de-
struction because they form the first protective barrier 
against inflammation (10, 13).
4. Antibodies and Immunoglobulins (Igs)
Immunoglobulins are glycoproteins synthesized by B 
lymphocytes and plasma cells that have the property 
Fig. 3. Some of the mechanisms implicated in the first stages of periodontal disease.
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of specifically binding to the antigen (2). Periodontal 
pathogens give rise to a marked humoral immune re-
sponse that can be measured locally in saliva or GCF 
or systemically in serum (7). Antigen titres vary widely 
among patients and after treatment of the disease (16). 
The presence of antibodies against periodontal patho-
gens in the GCF has been demonstrated in patients with 
periodontitis (Fig.3), with a predominance of IgG1, with 
a lesser presence of IgG2 and an even lower amount of 
IgG3 and IgG4.  IgA1 and IgA2 are found in advanced 
lesions (9, 16). Systemic exposure to pathogens of the 
oral cavity appears to occur in most patients, inducing 
the response of specific antibodies (17). The production 
of antibodies, especially IgG and IgA, is considered to 
play a protective role against periodontal disease patho-
genesis (16). Generally, the highest titles are associated 
with the most severe forms of the disease. Elevated an-
tibodies to Aa (17) have been reported in localised juve-
nile periodontitis.
Different antigen-binding models have been described 
in distinct groups of patients (18, 19). These differences 
in immunoreactivity profile can be related to hydro-
carbon molecules, LPS or proteins, although clear im-
munodominance models have yet to be established for 
any of the pathogens or patient groups. However, recent 
studies (20) suggested that the combination of bacterial 
colonisation and specific antibody responses can ef-
fectively discriminate between healthy individuals and 
those with periodontitis. It has been suggested that anti-
body responses to a given antigen are regulated by spe-
cific genes, so that the response may be more protective 
for some individuals than for others. Thus, some groups 
of patients may be more susceptible to periodontitis be-
cause they are unable to produce a high-affinity anti-
body response to the dominant bacterial antigens (21).   
The antibody response to specific characteristics of bac-
terial virulence appears to be critical for the resolution 
or non-progression of the disease. For example, elevated 
titres of antibodies against Pg proteases appear in late 
stages of chronic adult periodontitis and can block pro-
teolytic activity on C3 and Ig G (14).
Ebersole et al. (19) induced periodontitis in monkeys 
and obtained an elevated serum Ig G and Ig M response 
in proportion to the increase in the number of microor-
ganisms, supporting the theory that the host antibody 
response against periodontopathogens is generally pro-
tective.
Wheeler et al. (22) found that the severity of the disease 
was strongly associated with the amount of antibodies 
and that antibody titre defined the severity with greater 
accuracy than did level of microorganisms, since tran-
sient alterations in serum levels of antibodies against 
specific bacteria reveal changes in the nature of the in-
fectious load. On the other hand, it should be taken into 
account that the production of proteolytic enzymes by 
the microorganisms causes local degradation of Igs in 
the GCF (Fig. 3).
The type of dominant Ig differs according to the chemi-
cal nature of the antigens presented. Thus, protein anti-
gens induce a predominantly IgG1 and IgG4 response, 
whereas hydrocarbon antigens trigger an IgG2 response. 
Genetic factors also play a role, and Afro-Americans 
have higher serum levels of Aa infection-related IgG2 
in comparison to Caucasians, regardless of periodontal 
status (23). 
Scaling and root planing, fundamental in the treatment 
of periodontitis, induce a transient systemic bacteremia 
that re-immunises the patient by increasing the response 
of serum antibodies to resident oral bacteria. Part of the 
therapeutic response to scaling and root planning may 
be attributable to this humoral immunological response, 
which would increase toxin neutralisation and bacterial 
clearance (16).
All of these findings suggest a possible role for antibod-
ies as diagnostic indicators and markers of disease ac-
tivity. However, their value in clinical practice or for 
patient management has not proven satisfactory. Strictly 
speaking, elevated levels of antibodies against a peri-
odontal pathogen can only be interpreted as exposure to 
that pathogen (7).
Final considerations
Periodontal disease has an infectious aetiology. Its ex-
tent and severity depend on the interaction between 
the bacteria and the host response. The host response 
to pathogenic microorganisms involves a complex net-
work of cell and humoral components of the immune 
system, which interact with each other. The progression 
of gingivitis to periodontitis and the rate of progression 
of periodontitis cannot be explained solely by the pres-
ence of a microbiota. Presence of the bacteria is a neces-
sary but insufficient condition for onset of the disease.
Clinical studies have established that individual suscep-
tibility is of great importance in determining disease 
onset. Hence, an understanding of the factors that influ-
ence this susceptibility may be essential to determine 
periodontal disease activity. These factors include ge-
netic variation between individuals that conditions the 
appearance of different cell responses. Environmental 
risk factors, such as bacteria and stress, can alter the 
balance between host and microbiota, giving rise to the 
disease. This imbalance may be caused by the prolifera-
tion of an exogenous microorganism or the depression 
of an immune response due to environmental factors. 
If, on the other hand, the disease results from the exces-
sive growth of endogenous bacteria, a reduction in the 
host response function can permit this bacterial prolif-
eration.
The accepted model for the progression of periodonti-
tis has changed from the concept of a continuous and 
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slow process to a pattern of discontinuous progression 
characterised by episodes of exacerbation and remis-
sion. Thus, onset of the disease requires a pathogen of 
virulent strain and a host with the necessary genetic 
factors to trigger the disease. In other words, an indi-
vidual must be susceptible to a micro-organism and this 
must be present in sufficient numbers. Other bacterial 
species must promote or at least not inhibit the process, 
while the local environment must favour the expression 
of virulent bacterial properties. If the microorganism is 
able to evade all of these systems, it triggers the adap-
tive response, i.e., specific mechanisms. 
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